Chemitope Glycopeptide
Biotechnology, 140 58th St, Brooklyn, New York, 11220, United States, 1-10 Employees
Who is CHEMITOPE GLYCOPEPTIDE
Chemitope Glycopeptide is a Brooklyn-based biotechnology company specializing in the chemical synthesis of glycopeptides for research and clinical development. Leveraging two unique skill...
Read More
-
Headquarters: 140 58th St, Brooklyn, New York, 11220, United States
-
Date Founded: 2018
-
Employees: 1-10
-
Revenue: Under $1 Million
-
Active Tech Stack: See technologies
-
CEO:
Baptiste Aussedat
Email
Phone
Industry: Biotechnology
SIC Code: 2836
|
NAICS Code: 541714 |
Show More
Does something look wrong? Fix it. | View contact records from CHEMITOPE GLYCOPEPTIDE
Chemitope Glycopeptide Org Chart and Mapping
Similar Companies to Chemitope Glycopeptide
Pico Chemical Corporation
-
11-50
-
$ 5 Million to 10 Million
Regeneron
-
10001+
-
$ 1 Billion and Over
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Chemitope Glycopeptide
Answer: Chemitope Glycopeptide's headquarters are located at 140 58th St, Brooklyn, New York, 11220, United States
Answer: Chemitope Glycopeptide's official website is https://chemitopeglycopeptide.com
Answer: Chemitope Glycopeptide's revenue is Under $1 Million
Answer: Chemitope Glycopeptide's SIC: 2836
Answer: Chemitope Glycopeptide's NAICS: 541714
Answer: Chemitope Glycopeptide has 1-10 employees
Answer: Chemitope Glycopeptide is in Biotechnology
Answer: Chemitope Glycopeptide top competitors include: Pico Chemical Corporation , Regeneron
Answer: Chemitope Glycopeptide contact info: Phone number: Website: https://chemitopeglycopeptide.com
Answer: Chemitope Glycopeptide is a Brooklyn-based biotechnology company specializing in the chemical synthesis of glycopeptides for research and clinical development. Leveraging two unique skill sets in carbohydrate and peptide chemistry, we exert atomic-level structural control to produce homogeneous complex glycopeptides. Chemitopes research and development is focused on exploiting glycosylation in cancer and infectious diseases to develop glycopeptide immunogens for therapeutic and preventative vaccine applications. In addition, we provide comprehensive chemical synthesis and pre-clinical manufacturing support for our partners in academia, biotech, and the pharmaceutical industry.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month